Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals

Lancet. 2021 Mar 20;397(10279):1057-1058. doi: 10.1016/S0140-6736(21)00501-8. Epub 2021 Feb 25.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Viral / blood*
  • Antibodies, Viral / immunology
  • Asymptomatic Infections
  • COVID-19 / immunology
  • COVID-19 / prevention & control*
  • COVID-19 / virology
  • COVID-19 Vaccines / administration & dosage
  • COVID-19 Vaccines / immunology*
  • Case-Control Studies
  • Humans
  • Immunization Schedule
  • Immunogenicity, Vaccine
  • SARS-CoV-2 / immunology*

Substances

  • Antibodies, Viral
  • COVID-19 Vaccines
  • BNT162 vaccine